Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Ranked against 15 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LH | $29.8B | 35.1× | 16.9× | 2.1× | 7.2% | 28.8% | 6.3% | 10.2% | 6.2% | 2.5× | 310 |
| DGX | $28.4B | 29.5× | 15.8× | 2.6× | 11.8% | 33.2% | 9.0% | 13.8% | 7.7% | 2.5× | 328 |
| THC | $20.9B | 17.0× | 7.2× | 1.0× | 3.1% | — | 11.1% | 56.1% | 13.6% | 2.4× | 194 |
| EHC | $13.1B | 24.1× | 12.3× | 2.2× | 10.5% | — | 9.5% | 23.2% | 11.5% | 1.9× | 142 |
| BTSG | $12.5B | 72.2× | 40.7× | 1.0× | 28.2% | 11.8% | 1.5% | 10.2% | 4.4% | 6.6× | 91 |
| FMS | $10.6B | 5.0× | 5.2× | — | — | — | — | 11.5% | 6.7% | 2.1× | 64 |
| UHS | $10.3B | 7.8× | 5.8× | 0.6× | 9.7% | — | 8.6% | 20.5% | 12.4% | 1.8× | 144 |
| ENSG | $10.3B | 30.2× | 18.7× | 2.0× | 18.7% | 20.5% | 6.8% | 15.4% | 14.5% | -0.7× | 126 |
| CHE | $7.1B | 29.9× | 17.4× | 2.8× | 4.1% | 32.5% | 10.5% | 27.1% | 27.1% | -0.2× | 116 |
| PACS | $6.9B | 35.8× | — | 1.3× | 29.3% | — | 3.6% | 20.2% | 16.0% | — | 46 |
| RDNT | $5.5B | — | 27.1× | 2.7× | 11.5% | — | -0.9% | -1.7% | -0.9% | 1.5× | 66 |
| CON | $5.3B | 32.2× | 17.6× | 2.4× | 13.9% | — | 7.7% | 42.3% | 8.5% | 3.9× | 73 |
| LFST | $5.3B | — | 80.4× | 3.7× | 13.9% | — | 0.7% | 0.6% | 0.5% | 0.5× | 61 |
| CAI | $5.0B | — | 68.3× | 6.2× | 97.0% | — | -8.4% | -11.8% | -7.1% | -6.2× | 62 |
| OPCH | $4.7B | 24.9× | 14.0× | 0.8× | 13.0% | 19.3% | 3.7% | 15.7% | 8.3% | 2.3× | 72 |
| SHC | $4.5B | 58.9× | 16.3× | 3.9× | 5.7% | 55.5% | 6.7% | 12.9% | 2.8% | 4.6× | 58 |
Peers = companies sharing FMS's sector (Services-Misc Health & Allied Services, NEC) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 25% of free cash flow, leaving room to grow it and fund buybacks. Last year: $277.2M dividends + $0 buybacks = $277.2M returned on $1.11B FCF.
1 consecutive years of dividend increases · 3%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-11-20
How a revenue dollar becomes profit — FY2016
Each value shows its share of revenue below it (common-size).
| Line Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $5.27B 100.0% | $4.97B 100.0% | — | — | — |
| Cost of Revenue | $12.13B | $11.41B | $10.84B 205.8% | $9.87B 198.6% | $9.20B | $8.42B | $8.01B |
| Cost of Products | $1.47B | $1.55B | $1.70B 32.4% | $1.60B 32.3% | $1.55B | $1.56B | $1.44B |
| Cost of Services | $10.66B | $9.86B | $9.13B 173.4% | $8.27B 166.3% | $7.65B | $6.86B | $6.57B |
| Gross Profit | $5.62B | $5.18B | $5.00B 94.9% | $4.74B 95.3% | $4.60B | $4.15B | $3.84B |
| Research & Development | $146.5M | $128.1M | $122.1M 2.3% | $125.8M 2.5% | $111.6M | $110.8M | $96.5M |
| Selling, General & Admin | $3.13B | $2.95B | $2.64B 50.2% | $2.38B 47.9% | $2.22B | $2.00B | $1.82B |
| Operating Income | $2.64B | $2.33B | $2.25B 42.8% | $2.26B 45.4% | $2.22B | $2.07B | $1.92B |
| Interest Expense | -$363.4M | $508.0M | $495.4M 9.4% | $447.5M 9.0% | $470.5M | $356.4M | $305.5M |
| Interest & Investment Income | $46.6M | $116.6M | $84.2M 1.6% | $38.9M 0.8% | $44.5M | $59.8M | $25.4M |
| Other Income (Expense), net | — | — | — | — | — | $0 | $0 |
| Pretax Income | $2.23B | $1.94B | $1.84B 35.0% | $1.85B 37.2% | $1.93B | $1.78B | $1.64B |
| Income Tax Expense | $683.1M | $622.1M | $583.6M 11.1% | $592.0M 11.9% | $605.1M | $601.1M | $578.3M |
| Net Income | $1.24B | $1.03B | $1.05B 19.9% | $1.11B 22.3% | $1.19B | $1.07B | $978.5M |
| Per Share | |||||||
| EPS (Basic) | $4.07 | $3.38 | $3.46 | $3.65 | $3.89 | $3.54 | $3.25 |
| EPS (Diluted) | $4.06 | $3.38 | $3.45 | $3.65 | $3.87 | $3.51 | $3.24 |
| Weighted Avg Shares (Basic) | 305.7M | 304.4M | 302.3M | 301.9M | 301.1M | 299.0M | 296.8M |
| Weighted Avg Shares (Diluted) | 306.3M | 304.9M | 302.9M | 302.6M | 302.9M | 300.8M | 298.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2014, FY2015, FY2016). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $20.44 today, the market must believe free cash flow compounds 5.8%/yr for a decade (off $1.02B on the 3-yr avg basis).
On the basis ($1.00B) the requirement is 6.0%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 5.8% is more optimistic than its 6-yr track record.
Default is 10.0% — this company's computed cost of capital (published default — this company's cost of capital could not be computed), the same rate the Analysis tab discounts at.
2-stage DCF · 0.52B shares (market data) · net debt $7.06B
mean 7.7% · volatility σ 29% · implied rate exceeded in 3/6 yrs
Central path = implied 5.8%/yr growth; shaded band = ±1σ (29%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $747.2M is below the $764.3M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2016-12-31 (20-F).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~4.7% on $7.81B of debt.
Cash of $747.2M fully covers short-term debt of $605.7M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-11-20
Where each multiple sits in its own 5-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2016 · every deduction from revenue to net income
DuPont — the three levers
ROE 12% against ROIC 7% — 5% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | — | — | — | 198.6 | 205.8 | — | — |
| Gross Profit | — | — | — | 95.3 | 94.9 | — | — |
| R&D | — | — | — | 2.5 | 2.3 | — | — |
| SG&A | — | — | — | 47.9 | 50.2 | — | — |
| Operating Income | — | — | — | 45.4 | 42.8 | — | — |
| Income Tax | — | — | — | 11.9 | 11.1 | — | — |
| Net Income | — | — | — | 22.3 | 19.9 | — | — |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FMS: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Cost of capital cannot be computed, so the spread is unknown.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2013 | 95.3% | 45.4% | 22.3% |
| FY2014 | 94.9% | 42.8% | 19.9% |
Leverage and buybacks account for 5 points of the 12% return on equity in FY2016. The business earns 7% on the capital it employs; the rest is balance sheet.
ROE is on year-end equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: tax_rate.
Converts 1.01x of reported profit into free cash flow over 5 years, with accruals negative.
The cash conversion cycle could not be computed — receivables, inventory or cost of revenue is not reported — so the earliest accrual warning is not part of this verdict.
Covers interest 4.9x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 7.03x |
| 5% | 6.68x |
| 10% | 6.33x |
| 15% | 5.97x |
| 20% | 5.62x |
| 25% | 5.27x |
| 30% | 4.92x |
| 35% | 4.57x |
| 40% | 4.22x |
| 45% | 3.87x |
| 50% | 3.51x |
| 55% | 3.16x |
| 60% | 2.81x |
This schedule comes from a filing dated 2016-12-31, 3613 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2016-12-31 (20-F); cash from the 2016-12-31 balance sheet; FCF from FY2016.
Balance sheet at 2016-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $20.44, free cash flow must compound 5.81%/yr for 10 years. It has done 4.66%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2011 | 0.5% | 5.8% |
| FY2012 | 60.7% | 5.8% |
| FY2013 | −5.6% | 5.8% |
| FY2014 | −27.7% | 5.8% |
| FY2015 | 8.3% | 5.8% |
| FY2016 | 10.2% | 5.8% |
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
| Step | Amount | Running total |
|---|---|---|
| Net income | $1.24B | $1.24B |
| Share-based comp | $26M | $1.27B |
| Other non-cash & working capital | $871M | $2.14B |
| Operating cash flow | $2.14B | $2.14B |
| Capex | −$1.03B | $1.11B |
| Free cash flow | $1.11B | $1.11B |
| FCF after SBC | $1.08B | $1.08B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2011 | not reported | 8.8% | not reported |
| FY2012 | not reported | 7.9% | not reported |
| FY2013 | not reported | 0.6% | not reported |
| FY2014 | 5.9% | 5.5% | -0.5 points |
| FY2015 | not reported | 2.5% | not reported |
| FY2016 | not reported | 7.3% | not reported |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2010 | not reported | 36.9 days | 19.2 days | not reported |
| FY2011 | not reported | 41.9 days | 23.5 days | not reported |
| FY2012 | not reported | 41.1 days | 24.7 days | not reported |
| FY2013 | 223 days | 40.6 days | 20.1 days | 243.5 days |
| FY2014 | 222.1 days | 37.6 days | 19.3 days | 240.4 days |
| FY2015 | not reported | 42.9 days | 20.1 days | not reported |
| FY2016 | not reported | 42.4 days | 18.3 days | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2010 | -2.3 percent |
| FY2011 | -1.9 percent |
| FY2012 | -3.8 percent |
| FY2013 | -4.0 percent |
| FY2014 | -3.2 percent |
| FY2015 | -3.7 percent |
| FY2016 | -3.3 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2016) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.